| Literature DB >> 29844723 |
Abstract
Sodium lauroyl sarcosinate (SLS) is frequently used for the solubilization of inclusion bodies in vitro due to its structural similarity to lipid plasma membrane. There are many factors that could influence protein aggregation propensity, including overall protein surface charge and hydrophobicity. Here, the aggregation pathway of myoglobin protein was studied under different conditions (pH 3.5 and 7.4) in the presence of varying concentrations of SLS to evaluate the underlying forces dictating protein aggregation. Data obtained from Rayleigh light scattering, ThT binding assay, and far-UV CD indicated that SLS have different effects on the protein depending on its concentration and environmental conditions. In the presence of low concentrations of SLS (0.05-0.1 mM), no aggregation was detected at both pH conditions tested. Whereas, as we reach higher SLS concentrations (0.5-10.0 mM), myoglobin started forming larger-sized aggregates at pH 3.5 and not pH 7.4. These results suggest that electrostatics interactions as well as hydrophobic forces play an important role in SLS-induced myoglobin aggregation.Entities:
Keywords: Amorphous aggregates; Myoglobin; Protein aggregation; RLS, Rayleigh light scattering; SLS, sodium lauroyl sarcosinate; Sodium lauroyl sarcosinate; Surfactant; T-ThT, Thioflavin; pH
Year: 2018 PMID: 29844723 PMCID: PMC5962646 DOI: 10.1016/j.jsps.2018.02.005
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.330
Fig. 1A molecular model of negatively charged sodium lauroyl sarcosinate (SLS).
Fig. 2Rayleigh light scattering of myoglobin (0.2 mg ml−1) in the presence and absence of SLS was examined by taking scattering at 350 nm after excitation at 350 nm wavelength. Myoglobin was treated with different concentrations of SLS (0.0–10.0 mM) at pH 3.5 (-■-) and at pH 7.4 () was plotted. All the treated and untreated samples were incubated overnight prior to measurements at room temperature.
Spectroscopic data at pH 3.5 of SLS without protein added.
| [SLS] mM alone | F.I. at 485 nm | Light scattering at 350 nm | |
|---|---|---|---|
| 1 | 0 | 0.77 | 13.77 |
| 2 | 0.05 | 0.63 | 13.87 |
| 3 | 0.1 | 0.54 | 14.75 |
| 4 | 1.0 | 0.69 | 13.78 |
| 5 | 2.0 | 0.78 | 16.67 |
| 6 | 5.0 | 0.84 | 19.87 |
| 7 | 10.0 | 0.98 | 18.98 |
Fig. 3Morphology of myoglobin (0.2 mg ml−1) aggregates was determined by ThT fluorescence. ThT (5.0 μM) fluorescence intensity at 485 nm was plotted against SLS concentration at pH 3.5 (-■-) and 7.4 () after excitation at 440 nm.
Spectroscopic data under various experimental conditions including control.
| Condition | pH 3.5 | pH 7.4 | pH 10 | pH 11 | |||||
|---|---|---|---|---|---|---|---|---|---|
| F.I. at 485 nm | Light scattering at 350 nm | F.I. at 485 nm | Light scattering at 350 nm | F.I. at 485 nm | Light scattering at 350 nm | F.I. at 485 nm | Light scattering at 350 nm | ||
| 1 | Myoglobin alone | 0.77 | 13.77 | 0.34 | 14.65 | 0.32 | 13.15 | 0.29 | 13.01 |
| 2 | Myoglobin + 0.05 mM SLS | 0.88 | 15.38 | 0.65 | 24.87 | 0.41 | 12.73 | 0.33 | 13.17 |
| 3 | Myoglobin + 0.1 mM SLS | 0.98 | 26.95 | 0.65 | 33.53 | 0.55 | 13.43 | 0.50 | 14.87 |
| 4 | Myoglobin + 0.5 mM SLS | 1.29 | 195.19 | 0.87 | 33.97 | 0.61 | 13.54 | 0.56 | 16.32 |
| 5 | Myoglobin + 1.0 mM SLS | 3.64 | 310.98 | 0.89 | 52.96 | 0.54 | 12.79 | 0.58 | 15.98 |
| 6 | Myoglobin + 2.0 mM SLS | 12.76 | 528.25 | 0.59 | 45.75 | 0.60 | 15.85 | 0.65 | 16.15 |
| 7 | Myoglobin + 5.0 mM SLS | 18.38 | 738.8 | 0.63 | 47.54 | 0.42 | 17.50 | 0.62 | 15.90 |
| 8 | Myoglobin + 7.0 mM SLS | 18.98 | 807.65 | 0.67 | 45.65 | 0.56 | 14.31 | 0.59 | 13.89 |
| 9 | Myoglobin + 10.0 mM SLS | 19.76 | 854.76 | 0.69 | 75.76 | 0.73 | 15.12 | 0.87 | 14.76 |
Fig. 4Secondary structural change was evaluated in the presence different concentrations of SLS at pH 3.5 (Panel A) and pH 7.4 (Panel B). Far-UV CD spectra of myoglobin (0.2 mg ml−1) in the absence (-■-) and presence 0.05 mM (), 0.1 mM (), 0.7 mM (), 1.0 mM () and 1.5 mM () of SLS at pH 3.5. (Panel C) showed the aggregated spectra of myoglobin for more clarity.
Percentage of secondary structure change of myoglobin estimated at different conditions by K2D2 software.
| S. no. | Conditions | pH 3.5 | pH 7.4 | ||
|---|---|---|---|---|---|
| % α-helix | % β-sheet | % α-helix | % β-sheet | ||
| 1 | Myoglobin | 74.41 | 2.43 | 78.32 | 1.97 |
| 2 | Myoglobin + 0.05 mM SLS | 74.41 | 2.43 | 78.39 | 1.98 |
| 3 | Myoglobin + 0.1 mM SLS | 73.53 | 2.43 | 79.78 | 1.12 |
| 4 | Myoglobin + 0.7 mM SLS | 43.65 | 8.43 | 81.32 | 1.42 |
| 5 | Myoglobin + 1.0 mM SLS | 37.54 | 10.45 | 82.98 | 1.21 |
| 6 | Myoglobin + 1.5 mM SLS | 50.17 | 12.43 | 82.34 | 1.41 |